XYLT1 and Desbuquois dysplasia 2: A recent report by La Croix et al. described the presence of biallelic pathogenic variants in XYLT1 (including a trinucleotide repeat expansion associated with hypermetylation) in patients diagnosed with Baratela-Scott syndrome (BSS) which is characterized by short stature, facial dysmorphology and intellectual disability [43].